Identifying internal markets for resource redeployment von Dickler, Teresa A., Folta, Timothy B.

Volltext

The value of flexibility in multi‐business firms von Dickler, Teresa A., Folta, Timothy B., Giarratana, Marco S., Santaló, Juan

Volltext

When do firms benefit from overconfident CEOs ? The role of board expertise and power for technological breakthrough innovation von Kraft, Priscilla S., Dickler, Teresa A., Withers, Michael C.

Volltext

The value of flexibility in m ulti‐business firms von Dickler, Teresa A., Folta, Timothy B., Giarratana, Marco S., Santaló, Juan

Volltext

CEOs’ temporal focus, firm strategic change, and performance: Insights from a paradox perspective von Back, Pascal, Rosing, Kathrin, Dickler, Teresa Antonia, Kraft, Priscilla Sarai, Bausch, Andreas

Volltext

A Phase II Trial of Erlotinib in Combination with Bevacizumab in Patients with Metastatic Breast Cancer von DICKLER, Maura N, RUGO, Hope S, GILEWSKI, Teresa A, BROMBERG, Jacqueline F, SEIDMAN, Andrew D, D'ANDREA, Gabriella M, MOASSER, Mark M, MELISKO, Michele, PARK, John W, DANCEY, Janet, NORTON, Larry, HUDIS, Clifford A, EBERLE, Carey A, BROGI, Edi, CARAVELLI, James F, PANAGEAS, Katherine S, BOYD, Jeff, YEH, Benjamin, LAKE, Diana E, DANG, Chau T

Volltext

Weekly Trastuzumab and Paclitaxel Therapy for Metastatic Breast Cancer With Analysis of Efficacy by HER2 Immunophenotype and Gene Amplification von SEIDMAN, Andrew D, FORNIER, Monica N, GILEWSKI, Teresa, THEODOULOU, Maria, MOYNAHAN, Mary Ellen, MOASSER, Mark, SKLARIN, Nancy, DICKLER, Maura, D'ANDREA, Gabriella, CRISTOFANILLI, Massimo, RIVERA, Edgardo, HORTOBAGYI, Gabriel N, ESTEVA, Francisco J, NORTON, Larry, HUDIS, Clifford A, LEE TAN, KAPTAIN, Stamatina, BACH, Ariadne, PANAGEAS, Katherine S, ARROYO, Crispinita, VALERO, Vicente, CURRIE, Violante

Volltext

Immunization of High-Risk Breast Cancer Patients with Clustered sTn-KLH Conjugate plus the Immunologic Adjuvant QS-21 von GILEWSKI, Teresa A, RAGUPATHI, Govind, HOUGHTON, Alan N, LIVINGSTON, Philip O, DICKLER, Maura, POWELL, Shemeeakah, BHUTA, Sonal, PANAGEAS, Kathy, RAO KOGANTY, R, CHIN-ENG, Jeannette, HUDIS, Clifford, NORTON, Larry

Volltext

A phase Ib study of abemaciclib with therapies for metastatic breast cancer von Tolaney, Sara M., Beeram, Muralidhar, Beck, J. Thaddeus, Conlin, Alison Katherine, Dees, Elizabeth Claire, Dickler, Maura N., Helsten, Teresa L., Conkling, Paul R., Edenfield, William Jeffery, Richards, Donald A., Turner, P. Kellie, Cai, Na, Chan, Edward Michael, Pant, Shubham, Becerra, Carlos, Kalinsky, Kevin, Puhalla, Shannon, Rexer, Brent Neil, Burris, Howard A., Goetz, Matthew P.

Volltext

Phase I study of LJM716, BYL719, and trastuzumab in patients (pts) with HER2-amplified (HER2+) metastatic breast cancer (MBC) von Shah, Payal Deepak, Chandarlapaty, Sarat, Dickler, Maura N., Ulaner, Gary, Zamora, Stephen James, Sterlin, Valentina, Iasonos, Alexia, Coughlin, Christina Marie, Morozov, Alex, Ero, Joy, Rosen, Neal, Gilewski, Teresa, Fornier, Monica Nancy, Sklarin, Nancy T., Berger, Michael F., Moynahan, Mary Ellen, Hudis, Clifford A., Baselga, Jose, Modi, Shanu

Volltext

A virtual consult service to optimize clinical trial participation in patients with metastatic breast cancer von Cadoo, Karen Anne, Shah, Payal Deepak, Snyder Charen, Alexandra, Bromberg, Jacqueline, Comen, Elizabeth Anne, D'Andrea, Gabriella, Dang, Chau T., Gilewski, Teresa, Gucalp, Ayca, Lake, Diana, Seidman, Andrew David, Theodoulou, Maria, Traina, Tiffany A., Hudis, Clifford A., Norton, Larry, Moynahan, Mary Ellen, Modi, Shanu, Dickler, Maura N., Baselga, Jose, Chandarlapaty, Sarat

Volltext